- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Multiple Sclerosis Lesion
Total 12410 results
-
Assistance Publique - Hôpitaux de ParisFondation ARSEP/AFMCompletedRelapsing Remitting Multiple SclerosisFrance
-
MSDx, Inc.CompletedRelapsing Remitting Multiple SclerosisUnited States
-
OhioHealthCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Patient-Centered Outcomes Research Institute; Universita degli Studi di GenovaTerminatedRelapsing Remitting Multiple SclerosisItaly
-
Novartis PharmaceuticalsCompleted
-
Isfahan University of Medical SciencesShiraz University of Medical SciencesCompleted
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisSpain, Australia
-
GlaxoSmithKlineCompletedMultiple SclerosisUnited States, Bulgaria, Russian Federation, Spain, Germany, Czechia, Netherlands, Norway, Italy, Canada, Denmark
-
Charite University, Berlin, GermanyBayerTerminatedRelapsing Remitting Multiple SclerosisGermany
-
BiogenCompletedRelapsing Remitting Multiple SclerosisGermany
-
GlaxoSmithKlineCompleted
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing Remitting Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandNovartisCompletedRelapsing Remitting Multiple SclerosisSwitzerland
-
EMD SeronoMerck KGaA, Darmstadt, Germany; Ono Pharmaceutical Co. LtdTerminatedMultiple SclerosisUnited States, Belgium, Canada, Czech Republic, Germany, Japan, Poland, Russian Federation, Spain, Ukraine, Greece
-
Revalesio CorporationWithdrawnRelapsing Remitting Multiple SclerosisUnited States
-
University at BuffaloCharles University, Czech Republic; General University Hospital, PragueCompletedMultiple Sclerosis, Relapsing-remittingUnited States
-
University of Wisconsin, MadisonCompletedRelapsing Remitting Multiple SclerosisUnited States
-
University Hospital MuensterNovartisUnknownRelapsing Remitting Multiple SclerosisGermany
-
Johns Hopkins UniversityBiogenWithdrawn
-
BiogenElan PharmaceuticalsTerminatedRelapsing Remitting Multiple SclerosisUnited States, Czech Republic, Italy, Spain, Sweden, Latvia, Finland, Hungary, Poland, Slovenia, Australia, Canada, France
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedRelapsing Remitting Multiple Sclerosis
-
NovartisCompletedMultiple SclerosisUnited States, Turkey, Romania, United Kingdom, Poland, Austria, Canada, Australia
-
Tehran University of Medical SciencesUnknownRelapsing Remitting Multiple SclerosisIran, Islamic Republic of
-
BiogenCompleted
-
Eli Lilly and CompanyBioMS Technology Corp.CompletedRelapsing Remitting Multiple SclerosisSerbia, Bulgaria, Poland, Russian Federation, Slovakia, Ukraine
-
University Hospital Inselspital, BernePharmaPart; Laboratory: Viollier AG Spalenring 145 / 147 Postfach 4002 BaselCompletedMultiple SclerosisSwitzerland
-
Washington Neuropsychology Research GroupGenzyme, a Sanofi CompanyUnknownRelapsing Remitting Multiple SclerosisUnited States
-
Alabama Neurology Associates, PCBiogenUnknownRelapsing Remitting Multiple SclerosisUnited States
-
Multiple Sclerosis InstituteUnknown
-
Stanford UniversityKyverna TherapeuticsRecruitingMultiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
Abu Dhabi Stem Cells CenterRecruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveUnited Arab Emirates
-
Icahn School of Medicine at Mount SinaiWithdrawnRelapsing-remitting Multiple Sclerosis (RRMS)United States
-
BioMS Technology Corp.TerminatedMultiple Sclerosis, Secondary Progressive
-
Novartis PharmaceuticalsCompletedMultiple Sclerosis | Relapsing Multiple Sclerosis | Advancing Multiple SclerosisUnited States, Puerto Rico
-
Shirley Ryan AbilityLabNational Multiple Sclerosis SocietyNot yet recruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveUnited States
-
Shirley Ryan AbilityLabEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingMultiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis-Relapsing-RemittingUnited States
-
Boston Scientific CorporationTerminatedRelapsing Remitting Multiple SclerosisSpain, Germany, Belgium, Poland, France, Russian Federation
-
Centre Hospitalier Régional d'OrléansNational Scientific Research CentreCompletedMultiple Sclerosis | Multiple Sclerosis, Acute RelapsingFrance
-
Glasgow Caledonian UniversityUnknown
-
VA Office of Research and DevelopmentCompleted
-
National Institute of Allergy and Infectious Diseases...CompletedPrimary Progressive Multiple SclerosisUnited States
-
Anders SvenningssonVästerbotten County Council, SwedenCompletedProgressive Multiple SclerosisSweden
-
Genentech, Inc.Completed
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing Remitting Multiple Sclerosis
-
National Multiple Sclerosis SocietyCompletedMultiple SclerosisUnited States
-
Mahidol UniversityRecruitingNon-carious Cervical LesionThailand
-
AdventHealthRecruitingBarrett Esophagus | Esophageal Lesion | Gastrointestinal LesionsUnited States
-
Ryan J. HalterNational Institutes of Health (NIH); National Institute of Dental and Craniofacial... and other collaboratorsRecruiting
-
Istanbul UniversityCompletedEffect of an Additional Hydrophobic Adhesive Layer Application on the Class V Composite RestorationsNon Carious Cervical LesionTurkey
-
Tehran University of Medical SciencesCompletedMultiple Sclerosis | Mesenchymal Stem Cells | Secondary-Progressive Multiple SclerosisIran, Islamic Republic of